Literature DB >> 8477369

Acute hypercalcemia and severe bradycardia in a patient with breast cancer.

E Badertscher1, J W Warnica, D S Ernst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8477369      PMCID： PMC1491861     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man.

Authors:  E V McCloskey; A J Yates; M N Beneton; J Galloway; S Harris; J A Kanis
Journal:  Bone       Date:  1987       Impact factor: 4.398

Review 2.  Treatment of skeletal disease in breast cancer with clodronate.

Authors:  A H Paterson; D S Ernst; T J Powles; S Ashley; E V McCloskey; J A Kanis
Journal:  Bone       Date:  1991       Impact factor: 4.398

3.  Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia.

Authors:  S H Ralston; S J Gallacher; U Patel; F J Dryburgh; W D Fraser; R A Cowan; I T Boyle
Journal:  Lancet       Date:  1989-11-18       Impact factor: 79.321

Review 4.  Overview of cancer-related hypercalcemia: epidemiology and etiology.

Authors:  F M Muggia
Journal:  Semin Oncol       Date:  1990-04       Impact factor: 4.929

5.  A double-blind, crossover trial of intravenous clodronate in metastatic bone pain.

Authors:  D S Ernst; R N MacDonald; A H Paterson; J Jensen; P Brasher; E Bruera
Journal:  J Pain Symptom Manage       Date:  1992-01       Impact factor: 3.612
  5 in total
  2 in total

1.  Atrioventricular nodal dysfunction secondary to hyperparathyroidism.

Authors:  Athanasios Vosnakidis; Konstantinos Polymeropoulos; Paul Zarogoulidis; Ioannis Zarifis
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

2.  Efficacy of isoproterenol for treating amlodipine overdose resulting in bradycardia.

Authors:  Takeshi Ebihara; Masanori Morita; Masahiro Kawada; Koji Amano; Fumitaka Kato; Yasuki Nakata
Journal:  Acute Med Surg       Date:  2017-05-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.